SOCS2 and non-small cell lung carcinoma: Our findings uncover a mechanistic role for the circ_0006677/miR-578/SOCS2 signaling pathway in NSCLC progression and metabolic reprogramming, providing a potential therapeutic strategy for patients with NSCLC.